Will Pfizer Stock See Higher Levels After A Large 18% Rise In A Month?

The stock price of Pfizer (NYSE: PFE) has outperformed the broader indices. While the S&P500 index has seen a rise of 1% over the last month or so, PFE stock is up a solid 19%. This also compares with -10% returns for its peer – Merck, and 5% growth for Johnson & Johnson…

About the Author

has written 23527 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com